Mark N. Levine
Juravinski Cancer Centre · 489 works · 47,719 citations · h-index 99
Top works
- Hemorrhagic Complications of Anticoagulant Treatment
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
- Hemorrhagic Complications of Anticoagulant Treatment
- Responsiveness and validity in health status measurement: A clarification
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
- Quality of life in stage II breast cancer: an instrument for clinical trials.
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
- A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer
- Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.
- Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
- Optimal Therapeutic Range for Oral Anticoagulants
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
- Prevention of Deep Vein Thrombosis after Elective Hip Surgery
- Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Disection for Node-Negative Breast Cancer
- Regional Nodal Irradiation in Early-Stage Breast Cancer
- American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
- HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
- The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.